Grifols Stock Rises After-Hours on Alzheimer's Data and Energy Deal

Key Facts

1Grifols stock closed after-hours at EUR 9.57, representing a 0.63% increase.

2The company signed a 10-year renewable power purchase agreement with ENGIE for 40 GWh annually.

3The AMBAR program for Alzheimer's disease showed a 61% reduction in disease progression.

Grifols stock closed after-hours at EUR 9.57, representing a 0.63% increase according to AD HOC NEWS. The rise followed the company's announcement that its AMBAR program for Alzheimer's disease treatment showed a 61% reduction in disease progression. Additionally, the company signed a 10-year renewable power purchase agreement with ENGIE to supply 40 GWh of energy annually.

GRFS closed at EUR 7.30 on September 29, 2026, with the session seeing a low of EUR 7.24 and a high of EUR 7.42. The new energy agreement with ENGIE is designed to cover 66% of the company's electricity demand in Spain and avoid approximately 8,000 metric tons of carbon dioxide emissions per year, with the contract scheduled to run from 2027 through 2037.